GeneFerm Biotechnology Co (ROCO:1796) Days Sales Outstanding : 66.29 (As of Mar. 2024)

View and export this data going back to 2016. Start your Free Trial

What is GeneFerm Biotechnology Co Days Sales Outstanding?

GeneFerm Biotechnology Co's average Accounts Receivable for the three months ended in Mar. 2024 was NT$86.0 Mil. GeneFerm Biotechnology Co's Revenue for the three months ended in Mar. 2024 was NT$118.4 Mil. Hence, GeneFerm Biotechnology Co's Days Sales Outstanding for the three months ended in Mar. 2024 was 66.29.

The historical rank and industry rank for GeneFerm Biotechnology Co's Days Sales Outstanding or its related term are showing as below:

ROCO:1796' s Days Sales Outstanding Range Over the Past 10 Years
Min: 43.7 Med: 54.85 Max: 67.15
Current: 49.39

During the past 11 years, GeneFerm Biotechnology Co's highest Days Sales Outstanding was 67.15. The lowest was 43.70. And the median was 54.85.

ROCO:1796's Days Sales Outstanding is ranked better than
71.87% of 999 companies
in the Drug Manufacturers industry
Industry Median: 71.7 vs ROCO:1796: 49.39

GeneFerm Biotechnology Co's Days Sales Outstanding increased from Mar. 2023 (48.97) to Mar. 2024 (66.29).

GeneFerm Biotechnology Co Days Sales Outstanding Historical Data

The historical data trend for GeneFerm Biotechnology Co's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GeneFerm Biotechnology Co Days Sales Outstanding Chart

GeneFerm Biotechnology Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

Get a 7-Day Free Trial

67.15

61.52

55.34

53.71

43.70

GeneFerm Biotechnology Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Days Sales Outstanding	Get a 7-Day Free Trial															48.97	42.66	50.24	50.52	66.29

Competitive Comparison of GeneFerm Biotechnology Co's Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, GeneFerm Biotechnology Co's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

GeneFerm Biotechnology Co's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, GeneFerm Biotechnology Co's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where GeneFerm Biotechnology Co's Days Sales Outstanding falls into.

GeneFerm Biotechnology Co Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

GeneFerm Biotechnology Co's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (91.389	+	98.674)	/	2 )	/	793.77	*	365
=	95.0315					/	793.77	*	365
=	43.70

GeneFerm Biotechnology Co's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

	Days Sales Outstanding (Q: Mar. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2023 )	+	Accounts Receivable (A: Mar. 2024 ))	/	count )	/	Revenue (A: Mar. 2024 )	*	Days in Period
=	( (98.674	+	73.335)	/	2 )	/	118.386	*	365 / 4
=	86.0045					/	118.386	*	365 / 4
=	66.29

GeneFerm Biotechnology Co (ROCO:1796) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

GeneFerm Biotechnology Co Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of GeneFerm Biotechnology Co's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

GeneFerm Biotechnology Co (ROCO:1796) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » GeneFerm Biotechnology Co Ltd (ROCO:1796) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 33, Xingong Road, Xinying District, Tainan, TWN, 74144

Website

http://www.geneferm.com

GeneFerm Biotechnology Co Ltd is a fermentation company based in Taiwan. It is engaged in manufacturing health food and supplements which include Fermented Microbial products, Fermented Fungi products, Probiotics and Extraction, and Concentration products among others.

GeneFerm Biotechnology Co (ROCO:1796) Headlines

No Headlines